CS logo
small CS logo
National Institute on Drug Abuse, Biomedical Research Center (BRC)

Baltimore, Maryland, United States
Addiction treatment center in Baltimore, Maryland
251 Bayview Blvd, Baltimore, MD 21224

About National Institute on Drug Abuse, Biomedical Research Center (BRC)


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at National Institute on Drug Abuse, Biomedical Research Center (BRC)


During the past decade, National Institute on Drug Abuse, Biomedical Research Center (BRC) conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "National Institute on Drug Abuse, Biomedical Research Center (BRC)" #1 collaborator was "University of Maryland, College Park" with 2 trials as a collaborator and "National Institute of Mental Health (NIMH)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at National Institute on Drug Abuse, Biomedical Research Center (BRC)


According to Clinical.Site data, the most researched conditions in "National Institute on Drug Abuse, Biomedical Research Center (BRC)" are "Nicotine Dependence" (13 trials), "Drug Abuse" (8 trials), "Cocaine Dependence" (3 trials), "Schizophrenia" (3 trials) and "Cannabis" (2 trials). Many other conditions were trialed in "National Institute on Drug Abuse, Biomedical Research Center (BRC)" in a lesser frequency.

Clinical Trials Intervention Types at National Institute on Drug Abuse, Biomedical Research Center (BRC)


Most popular intervention types in "National Institute on Drug Abuse, Biomedical Research Center (BRC)" are "Drug" (6 trials), "Device" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "THC" (2 trials), "(+/-)3,4-methylenedioxymethamphetamine Hydrochloride, MDMA HCI Capsules" (1 trials), "Automated Contingency Management (ACM) software" (1 trials), "Cannabis Cigarette" (1 trials) and "MDMA" (1 trials). Other intervention names were less common.

Clinical Trials Genders at National Institute on Drug Abuse, Biomedical Research Center (BRC)


The vast majority of trials in "National Institute on Drug Abuse, Biomedical Research Center (BRC)" are 36 trials for "All" genders.

Clinical Trials Status at National Institute on Drug Abuse, Biomedical Research Center (BRC)


Currently, there are NaN active trials in "National Institute on Drug Abuse, Biomedical Research Center (BRC)". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in National Institute on Drug Abuse, Biomedical Research Center (BRC), undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in National Institute on Drug Abuse, Biomedical Research Center (BRC), 6 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".